Evidence map›Paper›PMID 26010447›Full record

ArticlePloS one2015

Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.

Zhaoxin Guo, Zhaoquan Xing, Xiangyu Cheng, Zhiqing Fang, Chao Jiang, Jing Su, Zunlin Zhou, Zhonghua Xu, Anders Holmberg, Sten Nilsson and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Zhaoxin GuoDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China.
Zhaoquan XingDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Xiangyu ChengDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zhiqing FangDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China.
Chao JiangDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Jing SuSchool of Nursing, Shandong University, Jinan, Shandong, China.
Zunlin ZhouDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zhonghua XuDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Anders HolmbergDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Sten NilssonDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Zhaoxu LiuDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China; School of Nursing, Shandong University, Jinan, Shandong, China; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Qilu Hospital of Shandong University · CNKarolinska Institutet · SEShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor development and progression are influenced by macrophages of the surrounding microenvironment. To investigate the influences of an inflammatory tumor microenvironment on the growth and metastasis of prostate cancer, the present study used a co-culture model of prostate cancer (PCa) cells with tumor-associated macrophage (TAM)-conditioned medium (MCM). MCM promoted PCa cell (LNCaP, DU145 and PC-3) growth, and a xenograft model in nude mice consistently demonstrated that MCM could promote tumor growth. MCM also stimulated migration and invasion in vitro. Somatostatin derivate (smsDX) significantly attenuated the TAM-stimulated proliferation, migration and invasion of prostate cancer. Immunohistochemistry revealed that NF-κB was over-expressed in PCa and BPH with chronic inflammatory tissue specimens and was positively correlated with macrophage infiltration. Further investigation into the underlying mechanism revealed that NF-κB played an important role in macrophage infiltration. SmsDX inhibited the paracrine loop between TAM and PCa cells and may represent a potential therapeutic agent for PCa.

Indexed as

AgedAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCell Line, TumorCell MovementCell NucleusCell ProliferationCell SurvivalCulture Media, ConditionedHumansImmunohistochemistryMacrophagesMaleMice, Inbred BALB CAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 antigen, humanCD68 MoleculeCulture Media, ConditionedNF-kappa BSomatostatinTranscription Factor RelA

Identifiers

PMID26010447
PMCPMC4444263
OpenAlexW2208499594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.